| Name | Title | Contact Details |
|---|
Forensic IT is a Edwardsville, IL-based company in the Software & Internet sector.
Datacastle Corporation is a Seattle, WA-based company in the Software and Internet sector.
Birch Grove Software is a Richardson, TX-based company in the Software & Internet sector.
Digital.ai is the intelligent value stream management company that enables Global 5000 enterprises to accelerate their digital transformation initiatives and deliver secure digital products their customers can trust. Digital.ai was formed by bringing together proven technology leaders in business agility, software delivery, application security, continuous testing, and AI-powered analytics into one integrated, intelligent value stream platform. Together, we have more than 50 years of experience providing critical business and technology solutions to over 1,500 companies around the world. The Digital.ai Value Stream Platform seamlessly integrates all the disparate tools and processes across the various value streams, uses data and AI/ML to create connective tissue between them, and provides the real-time, contextual insights required to drive and sustain successful digital transformation. With Digital.ai, enterprises have the visibility they’ve been seeking to deliver value, drive growth, increase profitability, reduce security risk, and improve customer experience.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.